Literature DB >> 19446731

Elucidation of chemerin and chemokine-like receptor-1 function in adipocytes by adenoviral-mediated shRNA knockdown of gene expression.

Kerry B Goralski1, Christopher J Sinal.   

Abstract

White adipose tissue has traditionally been regarded as an organ of energy storage and mobilization. However, it is now recognized that this tissue is also an active endocrine organ that secretes a variety of signaling molecules termed adipokines. These adipokines have diverse autocrine-, paracrine-, and endocrine-like actions that impact a variety of biological and physiological processes, including adipocyte differentiation, local and systemic inflammation, overall energy balance, blood pressure, and glucose and lipid metabolism. Given the regulatory influence on these critical functions, dysregulation of adipokine secretion is believed to be a major contributor to obesity-related disorders such as hypertension, diabetes, and cardiovascular disease. Chemerin is a small, secreted protein that has been reported to serve as a chemoattractant for cells of the immune system such as macrophages and immature dendritic cells that express the cognate receptor chemokine-like receptor-1 (CMKLR1). Using adenoviral- delivered, short hairpin RNAs (shRNAs) to suppress chemerin or CMKLR1 expression, we have demonstrated a novel role for chemerin/CMKLR1 signaling as a positive regulator of adipocyte differentiation and metabolic function in the 3T3-L1 model of adipogenesis. This experimental approach provides an efficient and powerful means to characterize the functional roles of genes known to be involved in adipocyte formation and metabolism as well as to identify novel roles for genes in this model and/or other cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446731     DOI: 10.1016/S0076-6879(09)05214-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  6 in total

1.  Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis.

Authors:  Mark E Issa; Shanmugam Muruganandan; Matthew C Ernst; Sebastian D Parlee; Brian A Zabel; Eugene C Butcher; Christopher J Sinal; Kerry B Goralski
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

2.  Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer.

Authors:  Dorina Rama-Esendagli; Gunes Esendagli; Guldal Yilmaz; Dicle Guc
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 3.  International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.

Authors:  Amanda J Kennedy; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2017-12-26       Impact factor: 25.468

Review 4.  G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Linsey J F Peters; Madeleine Müller; Selin Gencer; Yi Yan; Christian Weber; Yvonne Döring
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

5.  Divergence of Chemerin Reduction by an ATS9R Nanoparticle Targeting Adipose Tissue In Vitro vs. In Vivo in the Rat.

Authors:  Alexis Orr; Kunli Liu; Adam E Mullick; Xuefei Huang; Stephanie W Watts
Journal:  Biomedicines       Date:  2022-07-07

Review 6.  Adipokines and Inflammation: Focus on Cardiovascular Diseases.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Sandra Moraña-Fernández; Laura Anido-Varela; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Isabel Moscoso; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.